Bisoprolol transdermal

Drug Profile

Bisoprolol transdermal

Alternative Names: Bisono Tape; TY-0201

Latest Information Update: 26 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nitto Denko; Toa Eiyo
  • Class Antihypertensives; Heart failure therapies; Ischaemic heart disorder therapies; Propanolamines; Small molecules
  • Mechanism of Action Beta 1 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypertension
  • Phase III Atrial fibrillation
  • Phase II Heart failure

Most Recent Events

  • 19 Apr 2017 Toa Eiyo completes a phase III trial in Atrial fibrillation in Japan (JapicCTI152789)
  • 05 Jan 2017 Toa Eiyo completes a phase III trial in Atrial fibrillation in Japan (Transdermal) (JapicCTI-142700)
  • 13 Aug 2016 Toa Eiyo completes a clinical trial in Healthy volunteers in Japan (Transdermal) (UMIN000022622)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top